Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
6
×
boston top stories
cancer
6
×
genentech
6
×
life sciences
national blog main
national top stories
san francisco blog main
indiana blog main
indiana top stories
new york blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
eli lilly
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer immunotherapy
celgene
fda
pfizer
startups
agenus
boston
What
bio
cancer
drug
roundup
companies
fda
latest
pharmaceutical
acquire
address
agreed
alzheimer’s
annual
appetite
approval
approved
approves
big
billion
black
blueprint
bread
breast
broad
butter
buyout
cancer's
carries
cash
certain
clinical
conference
confidence
data
designed
diabetes
diamond’s
didn’t
different
digital
Language
unset
Current search:
genentech
×
cancer
×
" boston blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine